已发表论文

从临床广泛耐药的 ST648 大肠杆菌中分离出的新型携带 bla CTX-M-65 的 IncHI2 质粒 pE648CTX-M-65

 

Authors Lü Y, Kang H, Fan J

Received 8 July 2020

Accepted for publication 9 September 2020

Published 30 September 2020 Volume 2020:13 Pages 3383—3391

DOI https://doi.org/10.2147/IDR.S269766

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Editor who approved publication: Dr Sahil Khanna

Background: An ESBL, carbapenemase- and MCR-1-producing Escherichia coli  ST648 strain was isolated from the urine sample of a patient in a Chinese tertiary hospital in 2016.
Methods: The strain was fully sequenced by GridION X5 platform of Oxford Nanopore Technology.
Results: The sequence analysis showed that the extended-spectrum β-lactamases CTX-M-65 and OXA-1, the carbapenemase NDM-5, the MCR-1 were encoded, respectively, by three different resistance plasmids. The pE648CTX-M-65-carrying bla CTX-M-65 was a novel conjugative plasmid belonging to IncHI2 type; except for the bla CTX-M-65, it also carried resistance genes ble, floR, sul1, aph(4)-Ia, aac(3)-VI, aac(6 ʹ)-II, bla OXA-1catB, arr3  and tetA . Besides, an IncX4 plasmid pE648MCR-1-carrying mcr-1  and an IncX3 plasmid pE648NDM-5-carrying bla NDM-5 were also identified.
Conclusion: The three transferable resistance plasmids coexisting in the E. coli  ST648 isolate indicated the high risk to disseminate the extensively-drug-resistance among Enterobacteriaceae.
Keywords: CTX-M-65, MCR-1, NDM-5, extensively-drug-resistance, Escherichia coli




Figure 5 Sequence alignment of the pE648MCR-1 with...